Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F de Braud

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Tumori|June 30, 1993
Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanomaF de Braud, L Biganzoli, E Bajetta, et al.
Critical Reviews in Oncology/Hematology|March 29, 2000
Ifosfamide in the elderly: clinical considerations for a better drug managementT De Pas, G Curigliano, C Catania, et al.
The International Journal of Biological Markers|January 1, 1987
Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cellsF Campagnari, E Bombardieri, F de Braud, et al.
ESMO Open|January 28, 2021
Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapyG Fucà, A Spagnoletti, M Ambrosini, et al.
British Journal of Cancer|October 17, 2003
Imatinib administration in two patients with liver metastases from GIST and severe jaundiceT De Pas, R Danesi, C Catania, et al.
Clinical and Experimental Immunology|February 1, 1985
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterizationD Delia, G Cattoretti, A Bonati, et al.
The Journal of Vascular Access|July 20, 2007
Catheter rupture and distal embolisation: a rare complication of central venous portsR Biffi, F Orsi, F Grasso, et al.
Tumori|March 18, 1999
Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinomaM Colleoni, G Vicario, P Manente, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Trends in Pharmacological Sciences|August 2, 2001
Pharmacogenetic determinants of anti-cancer drug activity and toxicityR Danesi, F De Braud, S Fogli, et al.
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Tumori|June 30, 1993
Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanomaF de Braud, L Biganzoli, E Bajetta, et al.
Critical Reviews in Oncology/Hematology|March 29, 2000
Ifosfamide in the elderly: clinical considerations for a better drug managementT De Pas, G Curigliano, C Catania, et al.
The International Journal of Biological Markers|January 1, 1987
Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cellsF Campagnari, E Bombardieri, F de Braud, et al.
ESMO Open|January 28, 2021
Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapyG Fucà, A Spagnoletti, M Ambrosini, et al.
British Journal of Cancer|October 17, 2003
Imatinib administration in two patients with liver metastases from GIST and severe jaundiceT De Pas, R Danesi, C Catania, et al.
Clinical and Experimental Immunology|February 1, 1985
Detection of the common acute lymphoblastic leukaemia antigen (CALLA) on B cells from human fetal tissues. A multiple phenotypic characterizationD Delia, G Cattoretti, A Bonati, et al.
The Journal of Vascular Access|July 20, 2007
Catheter rupture and distal embolisation: a rare complication of central venous portsR Biffi, F Orsi, F Grasso, et al.
Tumori|March 18, 1999
Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinomaM Colleoni, G Vicario, P Manente, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Trends in Pharmacological Sciences|August 2, 2001
Pharmacogenetic determinants of anti-cancer drug activity and toxicityR Danesi, F De Braud, S Fogli, et al.
Pageof 14